Pediatr.Endocrinol.Diabetes Metab 2010;16(2):78-81
42 Additionally, DPN is linked to an increased risk of cardiovascular disease (CVD)
The future of GLP-1 RAs lies in their potential to address a wider array of metabolic disorders, supported by ongoing research and innovation (43)(47).GLP-1 receptor agonists, when integrated into comprehensive treatment plans, serve as tools in improving the lives of patients with T2DM and obesity
So, anything you can do to reduce stress and improve your sleep quality will benefit the effectiveness of GLP-1s. She notes that some GLP-1s, like tirzepatide (Mounjaro), have been shown to help treat sleep apnea in addition to obesity
This irregularity often occurs during the initial months of treatment as the body adjusts to metabolic changes
Note: the blue colouration of reconstituted GHK-Cu is normal and due to the copper complex